rs137854530

Variant summary

Our verdict is Pathogenic. The variant received 20 ACMG points: 20P and 0B. PVS1PS1_ModeratePM2PP5_Very_Strong

The NM_000516.7(GNAS):​c.1A>G​(p.Met1?) variant causes a start lost change. The variant allele was found at a frequency of 0.000000996 in 1,004,328 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).

Frequency

Genomes: not found (cov: 28)
Exomes 𝑓: 0.0000010 ( 0 hom. )

Consequence

GNAS
NM_000516.7 start_lost

Scores

6
4
6

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:4

Conservation

PhyloP100: 6.80

Publications

7 publications found
Variant links:
Genes affected
GNAS (HGNC:4392): (GNAS complex locus) This locus has a highly complex imprinted expression pattern. It gives rise to maternally, paternally, and biallelically expressed transcripts that are derived from four alternative promoters and 5' exons. Some transcripts contain a differentially methylated region (DMR) at their 5' exons, and this DMR is commonly found in imprinted genes and correlates with transcript expression. An antisense transcript is produced from an overlapping locus on the opposite strand. One of the transcripts produced from this locus, and the antisense transcript, are paternally expressed noncoding RNAs, and may regulate imprinting in this region. In addition, one of the transcripts contains a second overlapping ORF, which encodes a structurally unrelated protein - Alex. Alternative splicing of downstream exons is also observed, which results in different forms of the stimulatory G-protein alpha subunit, a key element of the classical signal transduction pathway linking receptor-ligand interactions with the activation of adenylyl cyclase and a variety of cellular reponses. Multiple transcript variants encoding different isoforms have been found for this gene. Mutations in this gene result in pseudohypoparathyroidism type 1a, pseudohypoparathyroidism type 1b, Albright hereditary osteodystrophy, pseudopseudohypoparathyroidism, McCune-Albright syndrome, progressive osseus heteroplasia, polyostotic fibrous dysplasia of bone, and some pituitary tumors. [provided by RefSeq, Aug 2012]
GNAS Gene-Disease associations (from GenCC):
  • McCune-Albright syndrome
    Inheritance: AD, Unknown Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • progressive osseous heteroplasia
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE, NO_KNOWN Submitted by: G2P, Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • pseudohypoparathyroidism type 1B
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Orphanet
  • pseudohypoparathyroidism type 1C
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Orphanet
  • pseudopseudohypoparathyroidism
    Inheritance: AD, Mitochondrial Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Orphanet
  • pseudohypoparathyroidism type 1A
    Inheritance: Mitochondrial, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 20 ACMG points.

PVS1
Start lost variant, next in-frame start position is after 38 pathogenic variants. Next in-frame start position is after 60 codons. Genomic position: 58895650. Lost 0.150 part of the original CDS.
PS1
Another start lost variant in NM_000516.7 (GNAS) was described as [Pathogenic] in ClinVar
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 20-58891727-A-G is Pathogenic according to our data. Variant chr20-58891727-A-G is described in ClinVar as Pathogenic. ClinVar VariationId is 15927.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GNASNM_000516.7 linkc.1A>G p.Met1? start_lost Exon 1 of 13 ENST00000371085.8 NP_000507.1 P63092-1O95467A0A0S2Z3H8
GNASNM_016592.5 linkc.*43-3885A>G intron_variant Intron 1 of 12 ENST00000371075.7 NP_057676.1 O95467-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GNASENST00000371085.8 linkc.1A>G p.Met1? start_lost Exon 1 of 13 1 NM_000516.7 ENSP00000360126.3 P63092-1
GNASENST00000354359.12 linkc.1A>G p.Met1? start_lost Exon 1 of 13 1 ENSP00000346328.7 P63092-4
GNASENST00000371095.7 linkc.1A>G p.Met1? start_lost Exon 1 of 12 1 ENSP00000360136.3 P63092-2
GNASENST00000371075.7 linkc.*43-3885A>G intron_variant Intron 1 of 12 1 NM_016592.5 ENSP00000360115.3 O95467-1
GNASENST00000676826.2 linkc.2069-3885A>G intron_variant Intron 1 of 12 ENSP00000504675.2 A0A7I2V5R6
GNASENST00000371102.8 linkc.2069-3885A>G intron_variant Intron 1 of 11 5 ENSP00000360143.4 Q5JWF2-2
GNASENST00000470512.6 linkc.-39+2374A>G intron_variant Intron 1 of 12 5 ENSP00000499552.2 A0A590UJQ9
GNASENST00000480232.6 linkc.-39+2178A>G intron_variant Intron 2 of 13 5 ENSP00000499545.2 A0A590UJQ9
GNASENST00000663479.2 linkc.-38-3885A>G intron_variant Intron 1 of 12 ENSP00000499353.2 A0A590UJQ9
GNASENST00000462499.6 linkc.-38-3885A>G intron_variant Intron 1 of 11 2 ENSP00000499758.2 A0A590UK28
GNASENST00000467227.6 linkc.-38-3885A>G intron_variant Intron 2 of 12 3 ENSP00000499681.2 A0A590UK28
GNASENST00000478585.6 linkc.-39+2374A>G intron_variant Intron 1 of 11 2 ENSP00000499762.2 A0A590UK28
GNASENST00000481039.6 linkc.-39+2819A>G intron_variant Intron 1 of 11 5 ENSP00000499767.2 A0A590UK28
GNASENST00000485673.6 linkc.-39+2178A>G intron_variant Intron 1 of 11 5 ENSP00000499334.2 A0A590UK28
GNASENST00000488546.6 linkc.-39+2909A>G intron_variant Intron 1 of 11 5 ENSP00000499332.2 A0A590UK28
GNASENST00000461152.6 linkc.*51+938A>G intron_variant Intron 1 of 2 5 ENSP00000499274.1 A0A590UJ46
GNASENST00000453292.7 linkc.*43-3885A>G intron_variant Intron 1 of 11 5 ENSP00000392000.2 O95467-1A2A2S1

Frequencies

GnomAD3 genomes
Cov.:
28
GnomAD4 exome
AF:
9.96e-7
AC:
1
AN:
1004328
Hom.:
0
Cov.:
32
AF XY:
0.00000206
AC XY:
1
AN XY:
486476
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
20428
American (AMR)
AF:
0.00
AC:
0
AN:
24594
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
12254
East Asian (EAS)
AF:
0.00
AC:
0
AN:
8256
South Asian (SAS)
AF:
0.00
AC:
0
AN:
42788
European-Finnish (FIN)
AF:
0.0000495
AC:
1
AN:
20218
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2430
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
839692
Other (OTH)
AF:
0.00
AC:
0
AN:
33668
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.225
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
28

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Pathogenic:2
Nov 20, 2024
GeneDx
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Initiation codon variants (Met1?) in GNAS likely lead to the use of an alternate initiation codon and the loss of the first 59 residues (PMID: 21713996, 2109828); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 2109828, 31546270, 27535533, 21713996, 31886927, 23533243) -

Aug 10, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that disruption of the initiator codon affects GNAS function (PMID: 21713996). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. ClinVar contains an entry for this variant (Variation ID: 15927). Disruption of the initiator codon has been observed in individual(s) with Albright’s hereditary osteodystrophy (PMID: 2109828, 21713996). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change affects the initiator methionine of the GNAS mRNA. The next in-frame methionine is located at codon 60. -

Pseudohypoparathyroidism Pathogenic:1
May 17, 1990
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Cushing syndrome;C0033806:Pseudohypoparathyroidism;C0033835:Pseudopseudohypoparathyroidism;C0242292:McCune-Albright syndrome;C0334041:Progressive osseous heteroplasia;C1864100:Pseudohypoparathyroidism type 1B;C2932716:Pseudohypoparathyroidism type 1C;C4540135:Pituitary adenoma 3, multiple types Pathogenic:1
Oct 31, 2018
Fulgent Genetics, Fulgent Genetics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.50
D
BayesDel_noAF
Pathogenic
0.48
CADD
Uncertain
23
DANN
Benign
0.95
DEOGEN2
Uncertain
0.45
.;T;.;.;T;T
Eigen
Benign
0.10
Eigen_PC
Benign
-0.041
FATHMM_MKL
Benign
0.64
D
LIST_S2
Uncertain
0.90
D;D;D;D;D;D
M_CAP
Pathogenic
0.96
D
MetaRNN
Pathogenic
0.99
D;D;D;D;D;D
MetaSVM
Pathogenic
0.94
D
PhyloP100
6.8
PROVEAN
Benign
-2.0
N;N;N;N;D;N
REVEL
Pathogenic
0.77
Sift
Uncertain
0.0010
D;D;D;D;D;D
Sift4G
Uncertain
0.0030
D;D;D;D;D;D
Polyphen
0.99, 0.99
.;D;.;D;.;.
Vest4
0.76
MutPred
0.99
Loss of catalytic residue at M1 (P = 0.155);Loss of catalytic residue at M1 (P = 0.155);Loss of catalytic residue at M1 (P = 0.155);Loss of catalytic residue at M1 (P = 0.155);Loss of catalytic residue at M1 (P = 0.155);Loss of catalytic residue at M1 (P = 0.155);
MVP
1.0
ClinPred
0.95
D
GERP RS
1.9
PromoterAI
-0.51
Under-expression
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.9
Mutation Taster
=2/198
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs137854530; hg19: chr20-57466782; API